Approval · Notice of Compliance 12512 · 2011
URSO: Notice of Compliance 12512
Issued July 27, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12512
- Date
- July 27, 2011
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Cholestatic liver diseases
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| URSO | Not yet assigned | — |
| URSO DS | Not yet assigned | — |